Cargando…

Differentiation value of miR-26b for major depressive disorder, schizophrenia, generalized anxiety disorder

INTRODUCTION: First episode and drug naive schizophrenia (SZ) patients comorbid with major depressive episode and generalized anxiety disorder (GAD) comorbid with major depressive disorder (MDD) are common in clinical practice, overlapping symptomatology during first presentation of MDD, SZ and GAD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kong, Lingming, Zhu, Xiaoli, Zhang, Liyi, Chen, Shengdong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461581/ https://www.ncbi.nlm.nih.gov/pubmed/37645356 http://dx.doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_385_22

Ejemplares similares

Long noncoding RNAs: New evidence for overlapped pathogenesis between major depressive disorder and generalized anxiety disorder
por: Cui, Xuelian, et al.
Publicado: (2017)

Long Non-Coding RNA: Potential Diagnostic and Therapeutic Biomarker for Major Depressive Disorder
por: Cui, Xuelian, et al.
Publicado: (2016)

Long noncoding RNA expression in peripheral blood mononuclear cells and suicide risk in Chinese patients with major depressive disorder
por: Cui, Xuelian, et al.
Publicado: (2017)

Disorder-specific cognitive profiles in major depressive disorder and generalized anxiety disorder
por: Hendriks, Sanne M, et al.
Publicado: (2014)

Aberrant Expression of Long Non-Coding RNAs in Schizophrenia Patients
por: Chen, Shengdong, et al.
Publicado: (2016)

Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder
por: Muscatello, Maria Rosaria Anna, et al.
Publicado: (2019)

Are Worry and Rumination Specific Pathways Linking Neuroticism and Symptoms of Anxiety and Depression in Patients with Generalized Anxiety Disorder, Major Depressive Disorder and Mixed Anxiety-Depressive Disorder?
por: Merino, Hipólito, et al.
Publicado: (2016)

New developments in the management of major depressive disorder and generalized anxiety disorder: role of quetiapine
por: Baune, Bernhard T
Publicado: (2008)

Hemolacria secondary to major depressive disorder and generalized anxiety disorder: A case report
por: Razeghian Jahromi, Leila, et al.
Publicado: (2023)

Self-stigma in borderline personality disorder – cross-sectional comparison with schizophrenia spectrum disorder, major depressive disorder, and anxiety disorders
por: Grambal, Ales, et al.
Publicado: (2016)

Effects of Treatment with Probiotics on Cognitive Function and Regulatory Role of Cortisol and IL-1β in Adolescent Patients with Major Depressive Disorder
por: Shi, Shaoli, et al.
Publicado: (2023)

Comorbid generalized anxiety disorder and its association with quality of life in patients with major depressive disorder
por: Zhou, Yongjie, et al.
Publicado: (2017)

Evaluation of depression and anxiety control in greek patients with major depressive disorder with/without generalized anxiety disorder and cardiovascular disease–pronoi study
por: Papanastasiou, P., et al.
Publicado: (2021)

Mitochondrial Variants in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder
por: Rollins, Brandi, et al.
Publicado: (2009)

Gut Microbiome: A Potential Indicator for Differential Diagnosis of Major Depressive Disorder and General Anxiety Disorder
por: Dong, Zaiquan, et al.
Publicado: (2021)

Effectiveness of vortioxetine in patients with major depressive disorder comorbid with generalized anxiety disorder: Results of the RECONNECT study
por: Christensen, Michael Cronquist, et al.
Publicado: (2022)

The comparison of severity and prevalence of major depressive disorder, general anxiety disorder and eating disorders before and after bariatric surgery
por: Matini, Diana, et al.
Publicado: (2014)

Investigation of miR-1202, miR-135a, and miR-16 in Major Depressive Disorder and Antidepressant Response
por: Fiori, Laura M, et al.
Publicado: (2017)

Promoter Hypomethylation of miR-124 Gene Is Associated With Major Depressive Disorder
por: Zeng, Duan, et al.
Publicado: (2021)

Evaluation of Coronavirus Anxiety Levels and Coping Strategies of Major Depressive Disorder, Generalized Anxiety Disorder, and Panic Disorder Patients During the Covid-19 Pandemic
por: Erden, Selime Celik, et al.
Publicado: (2023)

Disorder- and emotional context-specific neurofunctional alterations during inhibitory control in generalized anxiety and major depressive disorder
por: Liu, Congcong, et al.
Publicado: (2021)

Prospective mental imagery in patients with major depressive disorder or anxiety disorders
por: Morina, Nexhmedin, et al.
Publicado: (2011)

Shared and distinct functional connectivity of hippocampal subregions in schizophrenia, bipolar disorder, and major depressive disorder
por: Song, Yanzhuo, et al.
Publicado: (2022)

Risk Factors for Anxiety in Major Depressive Disorder Patients
por: Xin, Li-Min, et al.
Publicado: (2015)

Attribution retraining group therapy for outpatients with major depression disorder, generalized anxiety disorder, and obsessive-compulsive disorder: a pilot study()
por: Wang, Chun, et al.
Publicado: (2011)

Integrating proteomic and clinical data to discriminate major psychiatric disorders: Applications for major depressive disorder, bipolar disorder, and schizophrenia
por: Shin, Dongyoon, et al.
Publicado: (2022)

Major Depressive Episode and Generalized Anxiety Disorder Among Sexual Minority Adults in the United States
por: Exten, Cara, et al.
Publicado: (2020)

Emotional Roles of Mono-Aminergic Neurotransmitters in Major Depressive Disorder and Anxiety Disorders
por: Liu, Yi, et al.
Publicado: (2018)

Epigenomics of Major Depressive Disorders and Schizophrenia: Early Life Decides
por: Hoffmann, Anke, et al.
Publicado: (2017)

Serological evidences link toxoplasmosis with schizophrenia and major depression disorder
por: Al-Hussainy, Nabeel H., et al.
Publicado: (2015)

Regulatory Role of lncRNA NONHSAT089447 in the Dopamine Signaling Pathway in Schizophrenic Patients
por: Chen, Shengdong, et al.
Publicado: (2019)

Utilization of somatic healthcare in Croatian patients with schizophrenia spectrum disorder, major depression, PTSD and the general population
por: Jeleč, Vjekoslav, et al.
Publicado: (2019)

Prevalence of Comorbid Anxiety Disorders and Their Associated Factors in Patients with Bipolar Disorder or Major Depressive Disorder
por: Inoue, Takeshi, et al.
Publicado: (2020)

Common and Specific Functional Activity Features in Schizophrenia, Major Depressive Disorder, and Bipolar Disorder
por: Yang, Yongfeng, et al.
Publicado: (2019)

Disorder-Specific Profiles of Self-Perceived Emotional Abilities in Schizophrenia and Major Depressive Disorder
por: Weiss, Elisabeth M., et al.
Publicado: (2022)

Genetic Liabilities Differentiating Bipolar Disorder, Schizophrenia, and Major Depressive Disorder, and Phenotypic Heterogeneity in Bipolar Disorder
por: Richards, Alexander L., et al.
Publicado: (2022)

Classification for psychiatric disorders including schizophrenia, bipolar disorder, and major depressive disorder using machine learning
por: Yang, Qingxia, et al.
Publicado: (2022)

Efficacy of vilazodone on anxiety symptoms in patients with major depressive disorder
por: Thase, Michael E., et al.
Publicado: (2014)

Mapping the Presence of Anxiety Symptoms in Adults With Major Depressive Disorder
por: Ge, Fenfen, et al.
Publicado: (2021)

Major depression and generalized anxiety disorder among HTLV-I/II infected former blood donors
por: Guiltinan, Anne M, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ispi8das6q5q8b4kvia4ds7258